Literature DB >> 20713524

miR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response.

Michele Scarola1, Stefan Schoeftner, Claudio Schneider, Roberta Benetti.   

Abstract

Loss-of-function mutations of retinoblastoma family (Rb) proteins drive tumorigenesis by overcoming barriers to cellular proliferation. Consequently, factors modulating Rb function are of great clinical import. Here, we show that miR-335 is differentially expressed in human cancer cells and that it tightly regulates the expression of Rb1 (pRb/p105) by specifically targeting a conserved sequence motif in its 3' untranslated region. We found that by altering Rb1 (pRb/p105) levels, miR-335 activates the p53 tumor suppressor pathway to limit cell proliferation and neoplastic cell transformation. DNA damage elicited an increase in miR-335 expression in a p53-dependent manner. miR-335 and p53 cooperated in a positive feedback loop to drive cell cycle arrest. Together, these results indicate that miR-335 helps control proliferation by balancing the activities of the Rb and p53 tumor suppressor pathways. Further, they establish that miR-335 activation plays an important role in the induction of p53-dependent cell cycle arrest after DNA damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713524     DOI: 10.1158/0008-5472.CAN-10-0141

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  p53 is positively regulated by miR-542-3p.

Authors:  Yemin Wang; Jen-Wei Huang; Maria Castella; David George Huntsman; Toshiyasu Taniguchi
Journal:  Cancer Res       Date:  2014-04-24       Impact factor: 12.701

2.  NEAT1 regulates pancreatic cancer cell growth, invasion and migration though mircroRNA-335-5p/c-met axis.

Authors:  Jia Cao; Yi Zhang; Jiachun Yang; Sijia He; Mingming Li; Shiyan Yan; Ying Chen; Chunying Qu; Leiming Xu
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

3.  miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells.

Authors:  M Tomé; P López-Romero; C Albo; J C Sepúlveda; B Fernández-Gutiérrez; A Dopazo; A Bernad; M A González
Journal:  Cell Death Differ       Date:  2010-12-17       Impact factor: 15.828

4.  Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299.

Authors:  Huaqi Wang; Min Li; Ren Zhang; Yuanyuan Wang; Wenqiao Zang; Yunyun Ma; Guoqiang Zhao; Guojun Zhang
Journal:  Tumour Biol       Date:  2013-06-06

5.  miR-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs.

Authors:  Youngmi Kim; Hyuna Kim; Hyunmi Park; Deokbum Park; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  J Biol Chem       Date:  2014-08-19       Impact factor: 5.157

Review 6.  The bone marrow metastasis niche in retinoblastoma.

Authors:  Abbas Khosravi; Saeid Shahrabi; Mohammad Shahjahani; Najmaldin Saki
Journal:  Cell Oncol (Dordr)       Date:  2015-06-11       Impact factor: 6.730

7.  The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells.

Authors:  Lyndsay V Rhodes; Ashley M Nitschke; H Chris Segar; Elizabeth C Martin; Jennifer L Driver; Steven Elliott; Seung Yoon Nam; Meng Li; Kenneth P Nephew; Matthew E Burow; Bridgette M Collins-Burow
Journal:  Oncol Rep       Date:  2011-10-04       Impact factor: 3.906

8.  miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.

Authors:  Lei Shi; Dongyi Jiang; Guan Sun; Yi Wan; Shuguang Zhang; Yanjun Zeng; Tianhong Pan; Zhimin Wang
Journal:  J Neurooncol       Date:  2012-08-14       Impact factor: 4.130

Review 9.  New insights into p53 functions through its target microRNAs.

Authors:  Jun-Ming Liao; Bo Cao; Xiang Zhou; Hua Lu
Journal:  J Mol Cell Biol       Date:  2014-04-15       Impact factor: 6.216

10.  MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC).

Authors:  Émilie A Graham; Jean-François Mallet; Majed Jambi; Hiroshi Nishioka; Kohei Homma; Chantal Matar
Journal:  Cancer Biol Ther       Date:  2017-09-08       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.